Zeria Pharmaceutical Co Ltd
TSE:4559
Zeria Pharmaceutical Co Ltd
Pre-Tax Income
Zeria Pharmaceutical Co Ltd
Pre-Tax Income Peer Comparison
Competitive Pre-Tax Income Analysis
Latest Figures & CAGR of Competitors
Company | Pre-Tax Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Zeria Pharmaceutical Co Ltd
TSE:4559
|
Pre-Tax Income
¥9.5B
|
CAGR 3-Years
34%
|
CAGR 5-Years
13%
|
CAGR 10-Years
3%
|
|
Takeda Pharmaceutical Co Ltd
TSE:4502
|
Pre-Tax Income
¥52.8B
|
CAGR 3-Years
-48%
|
CAGR 5-Years
-16%
|
CAGR 10-Years
-10%
|
|
Daiichi Sankyo Co Ltd
TSE:4568
|
Pre-Tax Income
¥237.2B
|
CAGR 3-Years
47%
|
CAGR 5-Years
23%
|
CAGR 10-Years
8%
|
|
Otsuka Holdings Co Ltd
TSE:4578
|
Pre-Tax Income
¥163.5B
|
CAGR 3-Years
-6%
|
CAGR 5-Years
8%
|
CAGR 10-Years
-2%
|
|
Chugai Pharmaceutical Co Ltd
TSE:4519
|
Pre-Tax Income
¥444B
|
CAGR 3-Years
15%
|
CAGR 5-Years
28%
|
CAGR 10-Years
17%
|
|
Astellas Pharma Inc
TSE:4503
|
Pre-Tax Income
¥25B
|
CAGR 3-Years
-44%
|
CAGR 5-Years
-37%
|
CAGR 10-Years
-15%
|
See Also
What is Zeria Pharmaceutical Co Ltd's Pre-Tax Income?
Pre-Tax Income
9.5B
JPY
Based on the financial report for Mar 31, 2024, Zeria Pharmaceutical Co Ltd's Pre-Tax Income amounts to 9.5B JPY.
What is Zeria Pharmaceutical Co Ltd's Pre-Tax Income growth rate?
Pre-Tax Income CAGR 10Y
3%
Over the last year, the Pre-Tax Income growth was 31%. The average annual Pre-Tax Income growth rates for Zeria Pharmaceutical Co Ltd have been 34% over the past three years , 13% over the past five years , and 3% over the past ten years .